Your browser doesn't support javascript.
loading
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.
Dammeijer, Floris; De Gooijer, Cornedine J; van Gulijk, Mandy; Lukkes, Melanie; Klaase, Larissa; Lievense, Lysanne A; Waasdorp, Cynthia; Jebbink, Merel; Bootsma, Gerben P; Stigt, Jos A; Biesma, Bonne; Kaijen-Lambers, Margaretha E H; Mankor, Joanne; Vroman, Heleen; Cornelissen, Robin; Baas, Paul; Van der Noort, Vincent; Burgers, Jacobus A; Aerts, Joachim G.
Afiliação
  • Dammeijer F; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands. Electronic address: f.dammeijer@erasmusmc.nl.
  • De Gooijer CJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Gulijk M; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Lukkes M; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Klaase L; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Lievense LA; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Waasdorp C; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bootsma GP; Department of Pulmonary Medicine, Zuyderland Medical Centre, Heerlen, the Netherlands.
  • Stigt JA; Department of Pulmonary Medicine, Isala Hospital, Zwolle, the Netherlands.
  • Biesma B; Department of Pulmonary Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands.
  • Kaijen-Lambers MEH; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Mankor J; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Vroman H; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Cornelissen R; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
  • Baas P; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Van der Noort V; Department of Biometrics, Netherlands Cancer Institute Amsterdam, the Netherlands.
  • Burgers JA; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Aerts JG; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands. Electronic address: j.aerts@erasmusmc.nl.
EBioMedicine ; 64: 103160, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33516644
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitorização Imunológica / Desoxicitidina / Imunomodulação / Mesotelioma Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitorização Imunológica / Desoxicitidina / Imunomodulação / Mesotelioma Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article